Clinical Trial Update: Combination Chemotherapy in Patients With Newly Diagnosed BPDCN [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating combination chemotherapy in newly diagnosed Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blastic Plasmacytoid Dendritic Cell Neoplasm

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) | Phase 2 | Status: UNKNOWN